
iuvo Therapeutics
iuvo Therapeutics – iuvo Therapeutics.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | Early VC | ||
Total Funding | 000k |
EUR | 2019 | 2020 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Iuvo Therapeutics operates as a fully licensed GMP GDP pharmaceutical importer and wholesaler specializing in medical cannabis within the German market. The company serves a diverse clientele, including medical professionals, pharmacies, and patients seeking therapeutic cannabis solutions. Iuvo Therapeutics distinguishes itself through a commitment to quality, expertise, and cultural respect, ensuring that its products meet the highest standards of pharmaceutical rigor. The business model revolves around importing and wholesaling premium cannabis products, generating revenue through sales to healthcare providers and retail outlets. By partnering with Bathera, a company known for its meticulous cultivation and dedication to quality, Iuvo Therapeutics ensures that its offerings are not only effective but also crafted with care and precision. The company’s focus on quality and patient-centric solutions positions it as a trusted source in the medical cannabis industry.
Keywords: GMP GDP, pharmaceutical, importer, wholesaler, medical cannabis, Germany, quality, expertise, cultural respect, Bathera.